How Ph.D. was paid
$14.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Mark A. Goldsmith, M.D., Ph.D.President and Chief Executive Officer | $812,500 | $3,968,076 | $8,995,114 | $889,700 | $7,000 | $14,672,390 |
| Jack AndersChief Financial Officer | $523,333 | $831,096 | $1,882,882 | $343,800 | $7,000 | $3,588,111 |
| Stephen M. Kelsey, M.D., FRCP, FRCPathPresident, Research and Development | $625,833 | $1,491,084 | $3,378,112 | $461,200 | $7,000 | $5,963,229 |
| Margaret Horn, J.D.Chief Operating Officer | $582,666 | $1,165,164 | $2,639,727 | $426,500 | $7,000 | $4,821,057 |
| Jeffrey CisliniGeneral Counsel and Secretary | $523,750 | $896,280 | $2,030,559 | $261,000 | $7,000 | $3,718,589 |
What changed and why
- $14.7MCEO total compensation increased to $14,672,390 in fiscal 2025 from $10,079,491 in fiscal 2024.
- Stock and option awards represented the vast majority of the CEO's total direct compensation for the year.
- 98%Approximately 98% of the votes cast supported the say-on-pay proposal at the prior annual meeting.
- A new retirement policy for equity awards was adopted, effective January 1, 2026, for eligible employees.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.